JOSÉ MARÍA AGUADO GARCÍA-rekin lankidetzan egindako argitalpenak (8)

2024

  1. Efficacy and safety of a preventive strategy against tuberculosis in liver transplantation recipients including the treatment of latent infection with moxifloxacin

    Transplant Infectious Disease

2023

  1. Pyogenic liver abscesses in liver transplant recipients versus non-transplant population. Outcome and risk factors of patient survival

    Clinical Transplantation, Vol. 37, Núm. 6

2022

  1. Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: A comparative study of two consecutive periods

    Mycoses, Vol. 65, Núm. 5, pp. 517-525

2021

  1. Experience With Moxifloxacin for the Treatment of Latent Tuberculosis Infection in Liver Transplantation: A Single-Center Prospective Study

    Liver Transplantation, Vol. 27, Núm. 6, pp. 913-917

  2. T cell–mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19

    American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2785-2794

2020

  1. Biliary Complications After Liver Transplantation From Uncontrolled Donors After Circulatory Death: Incidence, Management, and Outcome

    Liver Transplantation, Vol. 26, Núm. 1, pp. 80-91

  2. Varied clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: Initial experience at a single center in Madrid, Spain

    Transplant Infectious Disease, Vol. 22, Núm. 5

2017

  1. Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey

    Transplant Infectious Disease, Vol. 19, Núm. 6